Cargando…

91. Establishing Proof of Concept for a Bivalent RSVpreF Subunit Vaccine for Maternal Immunization

BACKGROUND: Respiratory syncytial virus (RSV) is a major cause of infant morbidity and mortality worldwide and could be preventable by vaccination in pregnancy. METHODS: We conducted a randomized, placebo-controlled phase 2b trial evaluating safety, immunogenicity, and potential efficacy of a bivale...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simões, Eric A F, Madhi, Shabir A, Center, Kimberly J, Llapur, Conrado J, Novoa Pizarro, Jose M, Swanson, Kena A, Radley, David, McGrory, Stephanie B, Gomme, Emily A, Scott, Daniel A, Jansen, Kathrin U, Gruber, William C, Gurtman, Alejandra C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752436/ http://dx.doi.org/10.1093/ofid/ofac492.016

Ejemplares similares

1941. Coadministration of Bivalent Respiratory Syncytial Virus (RSVpreF) Vaccine With Influenza Vaccine in Older Adults
por: Baber, James A, et al.
Publicado: (2023)

1942. Potential Public Health Impact of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for Prevention of RSV among US Infants
por: Hanau, Ahuva, et al.
Publicado: (2023)

Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus Vaccine (RSVPreF3) in Mothers and Their Infants: A Phase 2 Randomized Trial
por: Bebia, Zourab, et al.
Publicado: (2023)

Immunogenicity of an AS01-adjuvanted respiratory syncytial virus prefusion F (RSVPreF3) vaccine in animal models
por: Bouzya, Badiaa, et al.
Publicado: (2023)

Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of Respiratory Syncytial Virus disease among infants in Canada: a simulation study
por: Shoukat, Affan, et al.
Publicado: (2023)

LB745. Respiratory Syncytial Virus (RSV) Prefusion F Protein Candidate Vaccine (RSVPreF3 OA) is Efficacious in Adults ≥ 60 Years of Age (YOA)
por: Ison, Michael G, et al.
Publicado: (2022)

Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial
por: Leroux-Roels, Isabel, et al.
Publicado: (2022)

2139. Immunogenicity, reactogenicity and safety of a Respiratory Syncytial Virus prefusion F (RSVPreF3) candidate vaccine co-administered with the seasonal quadrivalent influenza vaccine in older adults
por: Chandler, Reynaldo, et al.
Publicado: (2022)

121. A Respiratory Syncytial Virus Prefusion F Protein (RSVPreF3) Candidate Vaccine Administered in Older Adults in a Phase I/II Randomized Clinical Trial Is Immunogenic
por: Guiñazú, Javier Ruiz, et al.
Publicado: (2020)

1936. Efficacy of One Dose of the Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Adults ≥ 60 Years of Age Persists for 2 RSV Seasons
por: Ison, Michael G, et al.
Publicado: (2023)

A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine
por: Walsh, Edward E, et al.
Publicado: (2021)

1239. Different Dose Levels of a Respiratory Syncytial Virus Maternal Vaccine Candidate (RSVPreF3) Administered to Non-pregnant Women in a Randomized Clinical Trial Are Immunogenic and Well Tolerated
por: Schwarz, Tino, et al.
Publicado: (2020)

119. A Respiratory Syncytial Virus Prefusion F Protein (RSVPreF3) Candidate Vaccine Administered in Older Adults in a Phase I/II Randomized Clinical Trial Is Well Tolerated
por: Tica, Jelena, et al.
Publicado: (2020)

96. A Candidate Respiratory Syncytial Virus (RSV) Prefusion F Protein Investigational Vaccine (RSVPreF3 OA) Is Immunogenic when Administered in Adults ≥ 60 Years of Age: Results at 6 Months after Vaccination
por: Schwarz, Tino F, et al.
Publicado: (2022)

1632. Bivalent RSV Prefusion F-Based Subunit Vaccine Generates High Neutralizing Titers in Older Adults
por: Fukushima, Yasushi, et al.
Publicado: (2023)

Phase 1/2 Randomized Study of the Immunogenicity, Safety, and Tolerability of a Respiratory Syncytial Virus Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vaccine
por: Falsey, Ann R, et al.
Publicado: (2021)

1630. Clinical Profile of Acute Respiratory Illness (ARI) Events in the Phase 3 Trial The RSV Vaccine Efficacy Study iN Older Adults Immunized against RSV Disease (RENOIR)
por: Marc, Gonzalo Pérez, et al.
Publicado: (2023)

Anterior Subluxation after Total Hip Replacement Confirmed by Radiographs: Report of Two Cases
por: McGrory, Conor P., et al.
Publicado: (2011)

Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Coadministered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine
por: Peterson, James T, et al.
Publicado: (2021)

Why case reports matter
por: McGrory, Brian J.
Publicado: (2015)

The case for open access
por: McGrory, Brian J.
Publicado: (2015)

Note from the Editor
por: McGrory, Brian J.
Publicado: (2015)

Note from the Editor
por: McGrory, Brian J.
Publicado: (2016)

Note from the Editor
por: McGrory, Brian J.
Publicado: (2017)

In the zone
por: McGrory, Brian J.
Publicado: (2018)

Note from the Editor
por: McGrory, Brian J.
Publicado: (2018)

Note from the Editor
por: McGrory, Brian J.
Publicado: (2015)

Note from the Editor
por: McGrory, Brian J.
Publicado: (2019)

Viewpoint, a new type of Arthroplasty Today manuscript
por: McGrory, Brian J.
Publicado: (2019)

Note from the Editor
por: McGrory, Brian J.
Publicado: (2019)

Continuing medical education and Arthroplasty Today
por: McGrory, Brian J.
Publicado: (2019)

Letter to the Editor on “Disassociation of a Cold-Welded Bimodular Titanium Femoral Stem by Intraoperative Ice Cooling”
por: McGrory, Brian J.
Publicado: (2020)

385. Safety and Immunogenicity of a Variant-adapted Bivalent (Original/Omicron BA.4/BA.5) BNT162b2 COVID-19 Vaccine Given as a Booster (Dose 4) to 5- to 11-Year-Old Children Who Previously Received 3 Doses of Original BNT162b2
por: Paulsen, Grant C, et al.
Publicado: (2023)

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination
por: Bhorat, As’ad E., et al.
Publicado: (2015)

Surgical hexing can curse outcomes
por: McGrory, Brian J., et al.
Publicado: (2017)

Custom titanium sleeve for surgical treatment of mechanically assisted crevice corrosion in the well-fixed, noncontemporary stem in total hip arthroplasty
por: Leibiger, Thomas, et al.
Publicado: (2015)

“Off-label” Usage of an Oxidized Zirconium Femoral Head in Revision of a Total Hip Arthroplasty with Mechanically Assisted Crevice Corrosion and a Legacy Taper
por: Lachance, Andrew D., et al.
Publicado: (2021)

Use of locking plates for fixation of the greater trochanter in patients with hip replacement
por: Tetreault, Allison K., et al.
Publicado: (2016)

Total knee arthroplasty in a patient with ipsilateral calcific myonecrosis
por: Barron, Sivana Leigh, et al.
Publicado: (2018)

Adverse reaction to metal debris with concomitant incidental crystalline arthropathy in hip arthroplasty
por: Testa, Edward J., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_b5ib2tvqel568rikl133keh4ap